Editorial: Deciphering and targeting the mTOR pathway in hematologic malignancies.

Competing Interests: The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author declares that he was an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.